Ketamine: reclassification alone will not reduce harms

Reclassifying ketamine without accompanying public health measures would be a symbolic action rather than an effective strategy for reducing harm, according to the authors. They argue that regulatory changes alone are insufficient and must be paired with broader public health interventions to meaningfully address risks associated with ketamine use.

Study at a glance

Abstract

Without parallel public health action, reclassifying ketamine risks being a symbolic gesture rather than a strategy to reduce harm, write Adam Winstock, David Nutt, and Caroline Copeland